Jim Simons’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Jim Simons’s Portfolio KBIO Stock Details KBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-110,522	Closed	-$2.61M	–	3742
2015 Q4	$2.61M	Sell	110,522 -25,088	-19%	-$278K	0.01%	1942
2015 Q3	$259K	Buy	135,610 +65,026	+92%	+$171K	﹤0.01%	2826
2015 Q2	$271K	Buy	70,584 +26,810	+61%	+$114K	﹤0.01%	2914
2015 Q1	$172K	Buy	43,774 +10,661	+32%	+$47.8K	﹤0.01%	2923
2014 Q4	$458K	Buy	33,113 +17,255	+109%	+$246K	﹤0.01%	2461
2014 Q3	$197K	Sell	15,858 -14,805	-48%	-$204K	﹤0.01%	2556
2014 Q2	$559K	Buy	30,663 +27,008	+739%	+$462K	﹤0.01%	2283
2014 Q1	$79K	Buy	3,655 +1,339	+58%	+$38.8K	﹤0.01%	2729
2013 Q4	$82K	Buy	+2,316	New	+$77.6K	﹤0.01%	2752

Other funds holding KBIO

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Jim Simons's KBIO Position: Q1 2016 in Review

Jim Simons sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2016, closing a stake of 110,522 shares — an estimated $2.61M sold.

Jim Simons first reported a position in KBIO in Q4 2013 and held it in 9 quarters. The position peaked at $2.61M in Q4 2015. 1 fund tracked by Wall St. Rank holds KBIO as of Q1 2016.

Jim Simons reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2016 after selling out during the quarter.
Jim Simons sold 110,522 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2016, an estimated $2.61M.
Jim Simons first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q4 2013 and held it in 9 quarters.
Jim Simons's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $2.61M in Q4 2015.
1 fund tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2016.

Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.